240 related articles for article (PubMed ID: 11593564)
1. Therapeutic efficacy of transcatheter arterial embolization of primary hepatocellular carcinoma: discrepancy in different histopathologic subtypes.
Wang Y; Zhang J; Gao Y; Yu M; Gong Y; Yu G
Chin Med J (Engl); 1999 Mar; 112(3):264-8. PubMed ID: 11593564
[TBL] [Abstract][Full Text] [Related]
2. Multimodality treatment for patients with hepatocellular carcinoma: a single institution retrospective series.
Takano S; Watanabe Y; Ohishi H; Kono S; Nakamura M; Kubota N; Iwai S
Eur J Surg Oncol; 2000 Feb; 26(1):67-72. PubMed ID: 10718183
[TBL] [Abstract][Full Text] [Related]
3. Bland embolization of hepatocellular carcinoma using superabsorbent polymer microspheres.
Osuga K; Hori S; Hiraishi K; Sugiura T; Hata Y; Higashihara H; Maeda N; Tomoda K; Nakamura H
Cardiovasc Intervent Radiol; 2008; 31(6):1108-16. PubMed ID: 18543028
[TBL] [Abstract][Full Text] [Related]
4. Transcatheter arterial embolization in hepatocellular carcinoma: a long-term follow-up.
Nakao N; Kamino K; Miura K; Takayasu Y; Ohnishi M; Miura T
Radiat Med; 1992; 10(1):13-8. PubMed ID: 1316626
[TBL] [Abstract][Full Text] [Related]
5. [Significance of arterial infusion of SMANCS-dissolved Lipiodol in therapeutic strategies for hepatocellular carcinoma].
Jin-no K
Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():90-8. PubMed ID: 9512695
[TBL] [Abstract][Full Text] [Related]
6. A phase II trial of transcatheter arterial infusion chemotherapy with an epirubicin-Lipiodol emulsion for advanced hepatocellular carcinoma refractory to transcatheter arterial embolization.
Tanaka T; Ikeda M; Okusaka T; Ueno H; Morizane C; Ogura T; Hagihara A; Iwasa S
Cancer Chemother Pharmacol; 2008 Apr; 61(4):683-8. PubMed ID: 17541589
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of transcatheter arterial embolization prior to percutaneous tumor ablation in patients with hepatocellular carcinoma: a randomized controlled trial.
Akamatsu M; Yoshida H; Obi S; Sato S; Koike Y; Fujishima T; Tateishi R; Imamura M; Hamamura K; Teratani T; Shiina S; Ishikawa T; Omata M
Liver Int; 2004 Dec; 24(6):625-9. PubMed ID: 15566514
[TBL] [Abstract][Full Text] [Related]
8. [Efficacy of transcatheter arterial infusion chemotherapy and transcatheter arterial embolization in 132 patients with primary hepatocellular carcinoma].
Shi Z; Guo Y; Liu D
Zhonghua Zhong Liu Za Zhi; 1999 May; 21(3):211-3. PubMed ID: 11776839
[TBL] [Abstract][Full Text] [Related]
9. The role of transcatheter arterial embolization in patients with resectable hepatocellular carcinoma: a nation-wide, multicenter study.
Huang YH; Chen CH; Chang TT; Chen SC; Wang SY; Lee PC; Lee HS; Lin PW; Huang GT; Sheu JC; Tsai HM; Chau GY; Chiang JH; Lui WY; Lee SD; Wu JC
Liver Int; 2004 Oct; 24(5):419-24. PubMed ID: 15482337
[TBL] [Abstract][Full Text] [Related]
10. Hepatic perfusion index in evaluating treatment effect of transcatheter hepatic artery embolization in patients with hepatocellular carcinoma.
Lin WY; Wang SJ; Yeh SH
Neoplasma; 1995; 42(2):89-92. PubMed ID: 7617083
[TBL] [Abstract][Full Text] [Related]
11. Management of spontaneous bleeding due to hepatocellular carcinoma.
Recordare A; Bonariol L; Caratozzolo E; Callegari F; Bruno G; Di Paola F; Bassi N
Minerva Chir; 2002 Jun; 57(3):347-56. PubMed ID: 12029230
[TBL] [Abstract][Full Text] [Related]
12. Comparison of survival rates after bland arterial embolization and ablation versus surgical resection for treating solitary hepatocellular carcinoma up to 7 cm.
Maluccio M; Covey AM; Gandhi R; Gonen M; Getrajdman GI; Brody LA; Fong Y; Jarnagin W; D'Angelica M; Blumgart L; DeMatteo R; Brown KT
J Vasc Interv Radiol; 2005 Jul; 16(7):955-61. PubMed ID: 16002503
[TBL] [Abstract][Full Text] [Related]
13. [Styrene maleic acid neocarzinostatin-transcatheter embolization for hepatocellular carcinoma--third report].
Hasegawa I; Hirashima N
Gan To Kagaku Ryoho; 2002 Feb; 29(2):253-9. PubMed ID: 11865632
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of transcatheter arterial embolization therapy for small hepatocellular carcinomas: comparison with other treatments.
Arai K; Matsui O; Takashima T; Kadoya M; Yoshikawa J; Gabata T; Ueda K; Kawamori Y; Izumi R; Kobayashi K
Radiat Med; 1990; 8(5):191-8. PubMed ID: 1963696
[TBL] [Abstract][Full Text] [Related]
15. Transcatheter arterial embolization with only particles for the treatment of unresectable hepatocellular carcinoma.
Maluccio MA; Covey AM; Porat LB; Schubert J; Brody LA; Sofocleous CT; Getrajdman GI; Jarnagin W; Dematteo R; Blumgart LH; Fong Y; Brown KT
J Vasc Interv Radiol; 2008 Jun; 19(6):862-9. PubMed ID: 18503900
[TBL] [Abstract][Full Text] [Related]
16. [Transcatheter arterial embolization with hepatic arterial induction of endogenous TNF in hepatocellular carcinoma].
Takekoshi H; Oyama R
Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 2):2845-8. PubMed ID: 2476966
[TBL] [Abstract][Full Text] [Related]
17. [Analysis of survival in 240 patients with unresectable primary hepatocellular carcinoma treated with hepatic artery chemo-embolization].
Cheng L; Wang Z; Cai F
Zhonghua Zhong Liu Za Zhi; 1996 Sep; 18(5):362-4. PubMed ID: 9387276
[TBL] [Abstract][Full Text] [Related]
18. Radiofrequency ablation after transarterial embolization as therapy for patients with unresectable hepatocellular carcinoma.
Liao GS; Yu CY; Shih ML; Chan DC; Liu YC; Yu JC; Chen TW; Hsieh CB
Eur J Surg Oncol; 2008 Jan; 34(1):61-6. PubMed ID: 17434711
[TBL] [Abstract][Full Text] [Related]
19. Palliative treatment of hepatocellular carcinoma with transcatheter arterial embolization.
Savastano S; Feltrin GP; Neri D; da Pian P; Chiesura-Corona M; Roman E; Battaglia G; Gerunda G; Lise M; Miotto D
Acta Radiol; 1993 Jan; 34(1):26-9. PubMed ID: 7678975
[TBL] [Abstract][Full Text] [Related]
20. Long-term outcomes of transcatheter arterial chemoembolization with autologous blood clot for unresectable hepatocellular carcinoma.
Gunji T; Kawauchi N; Akahane M; Watanabe K; Kanamori H; Ohnishi S
Int J Oncol; 2002 Aug; 21(2):427-32. PubMed ID: 12118341
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
